385 related articles for article (PubMed ID: 25522257)
1. Survival of patients with stage IV lung cancer with diabetes treated with metformin.
Lin JJ; Gallagher EJ; Sigel K; Mhango G; Galsky MD; Smith CB; LeRoith D; Wisnivesky JP
Am J Respir Crit Care Med; 2015 Feb; 191(4):448-54. PubMed ID: 25522257
[TBL] [Abstract][Full Text] [Related]
2. The effect of statins on survival in patients with stage IV lung cancer.
Lin JJ; Ezer N; Sigel K; Mhango G; Wisnivesky JP
Lung Cancer; 2016 Sep; 99():137-42. PubMed ID: 27565929
[TBL] [Abstract][Full Text] [Related]
3. Metformin exposure is associated with improved progression-free survival in diabetic patients after resection for early-stage non-small cell lung cancer.
Medairos RA; Clark J; Holoubek S; Kubasiak JC; Pithadia R; Hamid F; Chmielewski GW; Warren WH; Basu S; Borgia JA; Liptay MJ; Seder CW
J Thorac Cardiovasc Surg; 2016 Jul; 152(1):55-61.e1. PubMed ID: 27157918
[TBL] [Abstract][Full Text] [Related]
4. Metformin Improves Survival in Patients with Pancreatic Ductal Adenocarcinoma and Pre-Existing Diabetes: A Propensity Score Analysis.
Amin S; Mhango G; Lin J; Aronson A; Wisnivesky J; Boffetta P; Lucas AL
Am J Gastroenterol; 2016 Sep; 111(9):1350-7. PubMed ID: 27430290
[TBL] [Abstract][Full Text] [Related]
5. Metformin use and survival after non-small cell lung cancer: A cohort study in the US Military health system.
Lin J; Gill A; Zahm SH; Carter CA; Shriver CD; Nations JA; Anderson WF; McGlynn KA; Zhu K
Int J Cancer; 2017 Jul; 141(2):254-263. PubMed ID: 28380674
[TBL] [Abstract][Full Text] [Related]
6. Survival benefit associated with metformin use in inoperable non-small cell lung cancer patients with diabetes: A population-based retrospective cohort study.
Chuang MC; Yang YH; Tsai YH; Hsieh MJ; Lin YC; Lin CK; Chen PC; Yang TM
PLoS One; 2018; 13(1):e0191129. PubMed ID: 29329345
[TBL] [Abstract][Full Text] [Related]
7. Effect of HIV on survival in patients with non-small-cell lung cancer in the era of highly active antiretroviral therapy: a population-based study.
Rengan R; Mitra N; Liao K; Armstrong K; Vachani A
Lancet Oncol; 2012 Dec; 13(12):1203-9. PubMed ID: 23164952
[TBL] [Abstract][Full Text] [Related]
8. Impact of metformin use on survival outcomes in non-small cell lung cancer treated with platinum.
Wen-Xiu X; Xiao-Wei Z; Hai-Ying D; Ying-Hui T; Si-Si K; Xiao-Fang Z; Huang P
Medicine (Baltimore); 2018 Dec; 97(51):e13652. PubMed ID: 30572481
[TBL] [Abstract][Full Text] [Related]
9. Population-based estimates of survival benefit associated with combined modality therapy in elderly patients with locally advanced non-small cell lung cancer.
Davidoff AJ; Gardner JF; Seal B; Edelman MJ
J Thorac Oncol; 2011 May; 6(5):934-41. PubMed ID: 21372743
[TBL] [Abstract][Full Text] [Related]
10. Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease.
Deepak JA; Ng X; Feliciano J; Mao L; Davidoff AJ
Ann Am Thorac Soc; 2015 May; 12(5):742-51. PubMed ID: 25760983
[TBL] [Abstract][Full Text] [Related]
11. Prognostic influence of metformin as first-line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes.
Tan BX; Yao WX; Ge J; Peng XC; Du XB; Zhang R; Yao B; Xie K; Li LH; Dong H; Gao F; Zhao F; Hou JM; Su JM; Liu JY
Cancer; 2011 Nov; 117(22):5103-11. PubMed ID: 21523768
[TBL] [Abstract][Full Text] [Related]
12. Metformin use and its effect on survival in diabetic patients with advanced non-small cell lung cancer.
Arrieta O; Varela-Santoyo E; Soto-Perez-de-Celis E; Sánchez-Reyes R; De la Torre-Vallejo M; Muñiz-Hernández S; Cardona AF
BMC Cancer; 2016 Aug; 16():633. PubMed ID: 27519177
[TBL] [Abstract][Full Text] [Related]
13. Metformin improves survival in lung cancer patients with type 2 diabetes mellitus: A meta-analysis.
Zeng S; Gan HX; Xu JX; Liu JY
Med Clin (Barc); 2019 Apr; 152(8):291-297. PubMed ID: 30173870
[TBL] [Abstract][Full Text] [Related]
14. Cost of Intensity-modulated Radiation Therapy for Older Patients with Stage III Lung Cancer.
Kale MS; Mhango G; Bonomi M; Federman A; Sigel K; Rosenzweig KE; Wisnivesky JP
Ann Am Thorac Soc; 2016 Sep; 13(9):1593-9. PubMed ID: 27299697
[TBL] [Abstract][Full Text] [Related]
15. Improved progression free survival for patients with diabetes and locally advanced non-small cell lung cancer (NSCLC) using metformin during concurrent chemoradiotherapy.
Wink KC; Belderbos JS; Dieleman EM; Rossi M; Rasch CR; Damhuis RA; Houben RM; Troost EG
Radiother Oncol; 2016 Mar; 118(3):453-9. PubMed ID: 26861738
[TBL] [Abstract][Full Text] [Related]
16. Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base.
Sher DJ; Koshy M; Liptay MJ; Fidler MJ
Cancer; 2014 Jul; 120(13):2060-8. PubMed ID: 24692108
[TBL] [Abstract][Full Text] [Related]
17. Metformin use improves the survival of diabetic combined small-cell lung cancer patients.
Kong F; Gao F; Liu H; Chen L; Zheng R; Yu J; Li X; Liu G; Jia Y
Tumour Biol; 2015 Sep; 36(10):8101-6. PubMed ID: 25983003
[TBL] [Abstract][Full Text] [Related]
18. Metformin Use and Kidney Cancer Outcomes in Patients With Diabetes: A Propensity Score Analysis.
Nayan M; Finelli A; Jewett MA; Juurlink DN; Austin PC; Kulkarni GS; Hamilton RJ
Clin Genitourin Cancer; 2017 Apr; 15(2):300-305. PubMed ID: 27424258
[TBL] [Abstract][Full Text] [Related]
19. Metformin therapy associated with survival benefit in lung cancer patients with diabetes.
Wan G; Yu X; Chen P; Wang X; Pan D; Wang X; Li L; Cai X; Cao F
Oncotarget; 2016 Jun; 7(23):35437-45. PubMed ID: 27105507
[TBL] [Abstract][Full Text] [Related]
20. Impact of estrogen monotherapy on survival in women with stage III-IV non-small cell lung cancer.
Heilbroner SP; Xanthopoulos EP; Buono D; Huang Y; Carrier D; Shah A; Kim J; Corradetti M; Wright JD; Neugut AI; Hershman DL; Cheng SK
Lung Cancer; 2019 Mar; 129():8-15. PubMed ID: 30797496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
